the aid library

LIST OPTIONS

Filter

9667

3MDG Maternal, Newborn and Child Health Indicator Guidelines [2nd ed.]

Three Millennium Development Goal Fund (3MDG) (2016) C1

Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated. more

Download (295)

View PDF (377)

School Eye Health Guidelines

The International Agency for the Prevention of Blindness (2024) CC

The IAPB School Eye Health Workgroup has released these guidelines to help deliver standardised comprehensive eye health services to more than 700 million children attending schools around the world. These guidelines direct the planning and implementation of school eye health initiatives for policym... more

Download (381)

View PDF (419)

Use of chest imaging in COVID-19 (Arab Version)
recommended

World Health Organization WHO (2020) C_WHO

This rapid advice guide examines the evidence and makes recommendations for the use of chest imaging in acute care of adult patients with suspected, probable or confirmed COVID-19. Imaging modalities considered are radiography, computed tomography and ultrasound. This guide addresses the care pathwa... more

Download (319)

View PDF (570)

Assessment of infection prevention and control practices in isolation areas in acute healthcare settings in the context of the novel coronavirus (COVID-19)
recommended

Pan American Health Organization PAHO (2020) C_WHO

Infection prevention and control practices need to be implemented to guarantee the safety of healthcare workers and patients in healthcare settings, it is fundamental to prevent cross contamination and containment of spread of COVID 19. As of the day of this publication, the following precautions ar... more

Download (532)

View PDF (610)

Plan National de Developpement Sanitaire 2018-2020

Ministère de la Santé, République du Benin (2018) C2

Le Plan National de Développement Sanitaire (PNDS) est la traduction de la Politique nationale en matière de santé. Le présent PNDS 2018-2022est fondéentre autres surle Plan National de Développement (PND), le Plan de Croissance pour le Développement Durable (PC2D), la politique du Secteur de... more

External Link

SuperAmma Campaign for Changing Handwashing Behavior

Compass; SuperAmma (2020) C2

Accessed: 02.05.2020 This campaign was designed to motivate mothers to wash their own hands with soap and to encourage their children to do the same. The campaign involved framing handwashing with soap without using the word "germs" and to frame the discussion as a matter of good manners which w... more

External Link

Guidance for the use of the WHO mass gathering risk assessment tools for religious gatherings in the context of COVID-19

World Health Organization WHO (2020) C_WHO

10 July 2020 Guidance for authorities and event organizers planning mass gatherings during the current COVID-19 pandemic The content of this Risk Assessment tool has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users. ... more

Download (388)

View PDF (599)

Using the 2013 revision of definitions and reporting framework for tuberculosis: list of indicators

World Health Organization (2014) C_WHO

Version 1.0, 2014-11-21 Introduction: This document lists TB indicators that can be derived from the recording and reporting tools defined in Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2). Geneva, World Health Organization; 2013. (http://www.who.int/t... more

External Link

External Link (370)

Ambitions and realities: Are Global Fund investments designed to achieve resilient and sustainable systems for health?

Salisbury N., Nawaz S., Abenaitwe J., et al. PLOS Global Public Health (2024) CC

Strengthening resilient and sustainable systems for health (RSSH) is central to the Global Fund’s strategy, however questions persist about the Global Fund’s role in the health systems strengthening space, and the extent to which investments are designed to achieve strengthening objectives, or j... more

External Link

External Link (394)

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi...lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

External Link (420)

Performance of Certest Biotec’s VIASURE yellow fever real time PCR detection kit

World Health Organization WHO (2025) C_WHO

On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as ... more

Download (248)

View PDF (190)

Chimioprévention du paludisme saisonnier par administration de sulfadoxine-pyriméthamine et d’amodiaquine aux enfants : guide de terrain

Organisation Mondiale de la Santé OMS (2023) CC

2ieme edtion. Cette deuxième édition s'appuie sur l'expérience de plus de 10 ans de déploiement de la CPS et reflète les changements introduits dans les lignes directrices de l'OMS pour le paludisme, le 3 juin 2022. L'objectif de cette publication est de partager ces bonnes pratiques afin d'am�... more

Download (187)

View PDF (146)

Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide

World Health Organization WHO (2023) C_WHO

2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and... more

Download (153)

View PDF (137)

Renforcement des capacités de lutte contre le paludisme : Guide du conseiller

HRH2030 (Human Resources for Health in 2030) USAID (United States Agency for International Development) (2021) C2

Le document intitulé « Guide du conseiller – Renforcement des capacités de lutte contre le paludisme » est un guide pratique destiné aux conseillers techniques travaillant au sein des Programmes nationaux de lutte contre le paludisme (PNLP), principalement dans des pays partenaires souten... more

Download (176)

View PDF (121)

Plan stratégique national de lutte contre le paludisme 2023-2026

Programme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et de l’Hygiène Publique du Togo République Togolaise, Ministère de la Santé et de l’Hygiène Publique (2023) C2

Le Plan Stratégique National de Lutte contre le Paludisme 2023–2026 du Togo définit les grandes orientations pour réduire de 65 % l’incidence et la mortalité liées au paludisme d’ici 2026, en comparaison avec les niveaux de 2022. Élaboré par le Programme National de Lutte contre le Pa... more

Download (159)

View PDF (208)

Programme Nationale de Lutte contre le Paludisme - Plan Stratégique National 2023-2027 - République de Guinée

Minsitère de la Santé et de l’hygiène Publique Direction nationale de l’épidemiologie et de la lutte contre la maladie (2023) C2

Le Plan Stratégique National de Lutte contre le Paludisme 2023–2027 de la Guinée vise à réduire de 80 % l’incidence et la mortalité liées au paludisme d’ici 2027, en s’appuyant sur les leçons des années précédentes. Il prévoit des actions renforcées de prévention (moustiquaire... more

Download (160)

View PDF (132)

Plan Stratégique National de Communication pour le Changement Social et des Comportements en matière de Lutte contre le Paludisme 2021–2025 (PSN CCSC 2021–2025)

PNLP Côte d’Ivoire (Programme National de Lutte contre le Paludisme) Ministère de la Santé et de l’Hygiène Publique (MSHP), Côte d’Ivoire (2020) C2

Le Plan Stratégique National de Communication pour le Changement Social et des Comportements en matière de Lutte contre le Paludisme 2021–2025 de la Côte d’Ivoire définit les grandes lignes pour améliorer la prévention et la prise en charge du paludisme à travers la communication. Il vise... more

Download (148)

View PDF (113)

Stratégie intégrée de Communication pour la Lutte contre le Paludisme au Sénégal

Programme National de Lutte contre le Paludisme (PNLP), Sénégal Ministère de la Santé et de l’Action Sociale, République du Sénégal (2016) C2

La Stratégie intégrée de communication pour la lutte contre le paludisme au Sénégal (2016) vise à renforcer la prévention et la prise en charge du paludisme par des actions de communication efficaces. Elle combine plaidoyer, mobilisation sociale et communication pour le changement de comporte... more

External Link

External Link (170)

Malaria Prophylaxis

DeVos, E.; Dunn, N. (2023) C2

Malaria is an infection caused by Plasmodium species endemic to most parts of Africa, South America, East Asia, and parts of Europe and the Middle East. At least 10 to 30 thousand of the 125 million travelers to these areas are infected each year. All visitors to endemic areas should receive counsel... more

Download (100)

View PDF (71)

Standards for Providing Quality R Palliative Care Across Africa

African Palliative Care Association APCA (2011) C2

The African Palliative Care Association is pleased to publish the first edition of Palliative Care Standards for Africa. The development of these standards was achieved through wide consultation with service beneficiaries and providers, and they have been developed to suit different levels of ... more

Use of chest imaging in COVID-19 (Arab Version) recommended

Assessment of infection prevention and control practices in isolation areas in acute healthcare settings in the context of the novel coronavirus (COVID-19) recommended

Use of chest imaging in COVID-19 (Arab Version)
recommended

Assessment of infection prevention and control practices in isolation areas in acute healthcare settings in the context of the novel coronavirus (COVID-19)
recommended